BofA Prices Deal Below Last Closing Price of $51.68
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 21 2026
0mins
The deal priced below last closing price of $51.68. BofA is acting as sole book running manager for the offering.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AHR
Wall Street analysts forecast AHR stock price to rise
12 Analyst Rating
11 Buy
1 Hold
0 Sell
Strong Buy
Current: 48.890
Low
47.00
Averages
55.25
High
60.00
Current: 48.890
Low
47.00
Averages
55.25
High
60.00
About AHR
American Healthcare REIT, Inc. is a self-managed real estate investment trust that acquires, owns and operates a diversified portfolio of clinical healthcare real estate properties, focusing primarily on senior housing, skilled nursing facilities (SNFs), outpatient medical (OM), buildings and other healthcare-related facilities. It owns and operates its integrated senior health campuses (ISHC) and senior housing operating properties (SHOP). Its segments include ISHC, OM, SHOP and triple-net leased properties. ISHC segment provides a range of independent living, assisted living, memory care, skilled nursing services and certain ancillary businesses. OM segment includes buildings that are leased to multiple tenants under separate leases. SHOP segment includes senior housing, which offers assisted living care, independent living, memory care or skilled nursing services. Its triple-net leased properties segment includes senior housing, skilled nursing facilities and hospital investments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
American Healthcare REIT Prices Public Offering of 14 Million Shares
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares of common stock, expected to generate approximately $705.6 million in gross proceeds, with a closing date set for May 22, 2026, indicating the company's proactive approach to capital markets.
- Underwriter Role: BofA Securities acts as the underwriter for the offering and has been granted a 30-day option to purchase an additional 2.1 million shares, which could further enhance the company's capital structure and liquidity if exercised.
- Forward Sale Agreement: The company entered into a forward sale agreement with BofA Securities, expecting to settle within 24 months, and if the underwriter's option is fully exercised, the total shares could increase to 16.1 million, thereby boosting the company's financing capabilities in the market.
- Planned Use of Proceeds: The company intends to contribute the net proceeds from the forward sale agreement to its operating partnership, highlighting its focus on future investment opportunities and aiming to enhance overall business growth potential.
See More
American Healthcare REIT Prices Public Offering of 14 Million Shares
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares at approximately $50.4 per share, expecting gross proceeds of about $705.6 million, reflecting strong market demand and investor confidence in the company.
- Underwriting Arrangement: BofA Securities acts as the underwriter and has been granted a 30-day option to purchase an additional 2.1 million shares, a flexible underwriting strategy that may enhance the company's liquidity and market adaptability.
- Use of Proceeds: The company intends to contribute the net proceeds from the offering to its operating partnership for general corporate purposes and future investments, indicating a proactive approach to business expansion and strategic planning.
- Market Impact: The successful pricing and imminent closing of this offering are expected to bolster the company's market position in the healthcare real estate sector, strengthening its capital structure and laying the groundwork for future growth.
See More
American Healthcare REIT Launches Public Offering of 14 Million Shares
- Public Offering Launch: American Healthcare REIT (AHR) announced the launch of an underwritten public offering of 14 million shares of common stock through a forward sale agreement, which is expected to provide funding for future investments.
- Additional Share Option: The underwriter is expected to receive a 30-day option to purchase up to an additional 2.1 million shares, enhancing market liquidity and providing more opportunities for investors.
- Clear Use of Proceeds: The company stated it expects to settle the forward sale agreement within about 24 months, with net proceeds intended for general corporate purposes, including potential future investments, demonstrating its strategic planning for business expansion.
- Future Performance Guidance: American Healthcare REIT also outlined its 2026 NFFO per share guidance of $2.03 to $2.09, with same-store NOI growth target raised to 9%-12%, reflecting the company's confidence in future growth.
See More
American Healthcare REIT Reports Strong Q1 Earnings with Raised Guidance
- Consistent Same-Store NOI Growth: American Healthcare REIT achieved a same-store NOI growth of 12.1% in Q1 2026, marking the ninth consecutive quarter of double-digit growth, which underscores the company's robust performance in core operations and is likely to enhance investor confidence.
- Strong SHOP Segment Performance: The SHOP segment reported a remarkable same-store NOI growth of 19.7% in Q1, with $249.2 million in acquisitions, indicating the company's advantageous position in the rapidly growing healthcare real estate market and driving future revenue growth.
- Improved Financial Health: As of March 31, 2026, the company's net debt to annualized EBITDA ratio improved to 3.0x, down from 3.4x at the end of 2025, demonstrating effective financial management that could enhance credit ratings and financing capabilities.
- Optimistic Outlook: Management raised the 2026 same-store NOI growth guidance to 9% to 12% and increased the NFFO per share guidance to $2.03 to $2.09, reflecting confidence in future market demand and likely attracting more investor interest.
See More
American Healthcare REIT (AHR) Q1 2026 Transcript
See More
Welltower Shares Face Downside Risk Amidst Aggressive Compensation Concerns
- Executive Compensation Controversy: Welltower's ten-year executive program may facilitate a transfer of wealth from shareholders to management, with CEO Shankh Mitra's potential award reaching approximately $2.6 billion, raising serious governance concerns that could undermine investor confidence.
- Significant Valuation Risks: Currently trading at $300 per share, Welltower's valuation is estimated to be 35%-60% higher than peer averages, indicating a potential for substantial downside, prompting investors to carefully assess their holding risks.
- Investor Migration Trend: With Welltower's asset value trading at a 144% premium compared to Ventas and American Healthcare REIT, investors switching to these alternatives could receive 50% more asset value, reflecting market dissatisfaction with aggressive executive compensation structures.
- Historical Lessons as Warnings: Alexandria Real Estate Equities' stock peaked at $224 in 2021 but plummeted 80% due to excessive management compensation and market cycle changes, serving as a cautionary tale for Welltower shareholders to remain vigilant against similar risks.
See More
American Healthcare REIT Prices Public Offering of 14 Million Shares
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares of common stock, expected to generate approximately $705.6 million in gross proceeds, with a closing date set for May 22, 2026, indicating the company's proactive approach to capital markets.
- Underwriter Role: BofA Securities acts as the underwriter for the offering and has been granted a 30-day option to purchase an additional 2.1 million shares, which could further enhance the company's capital structure and liquidity if exercised.
- Forward Sale Agreement: The company entered into a forward sale agreement with BofA Securities, expecting to settle within 24 months, and if the underwriter's option is fully exercised, the total shares could increase to 16.1 million, thereby boosting the company's financing capabilities in the market.
- Planned Use of Proceeds: The company intends to contribute the net proceeds from the forward sale agreement to its operating partnership, highlighting its focus on future investment opportunities and aiming to enhance overall business growth potential.
See More
American Healthcare REIT Prices Public Offering of 14 Million Shares
- Offering Size: American Healthcare REIT announced a public offering of 14 million shares at approximately $50.4 per share, expecting gross proceeds of about $705.6 million, reflecting strong market demand and investor confidence in the company.
- Underwriting Arrangement: BofA Securities acts as the underwriter and has been granted a 30-day option to purchase an additional 2.1 million shares, a flexible underwriting strategy that may enhance the company's liquidity and market adaptability.
- Use of Proceeds: The company intends to contribute the net proceeds from the offering to its operating partnership for general corporate purposes and future investments, indicating a proactive approach to business expansion and strategic planning.
- Market Impact: The successful pricing and imminent closing of this offering are expected to bolster the company's market position in the healthcare real estate sector, strengthening its capital structure and laying the groundwork for future growth.
See More
American Healthcare REIT Launches Public Offering of 14 Million Shares
- Public Offering Launch: American Healthcare REIT (AHR) announced the launch of an underwritten public offering of 14 million shares of common stock through a forward sale agreement, which is expected to provide funding for future investments.
- Additional Share Option: The underwriter is expected to receive a 30-day option to purchase up to an additional 2.1 million shares, enhancing market liquidity and providing more opportunities for investors.
- Clear Use of Proceeds: The company stated it expects to settle the forward sale agreement within about 24 months, with net proceeds intended for general corporate purposes, including potential future investments, demonstrating its strategic planning for business expansion.
- Future Performance Guidance: American Healthcare REIT also outlined its 2026 NFFO per share guidance of $2.03 to $2.09, with same-store NOI growth target raised to 9%-12%, reflecting the company's confidence in future growth.
See More
American Healthcare REIT Reports Strong Q1 Earnings with Raised Guidance
- Consistent Same-Store NOI Growth: American Healthcare REIT achieved a same-store NOI growth of 12.1% in Q1 2026, marking the ninth consecutive quarter of double-digit growth, which underscores the company's robust performance in core operations and is likely to enhance investor confidence.
- Strong SHOP Segment Performance: The SHOP segment reported a remarkable same-store NOI growth of 19.7% in Q1, with $249.2 million in acquisitions, indicating the company's advantageous position in the rapidly growing healthcare real estate market and driving future revenue growth.
- Improved Financial Health: As of March 31, 2026, the company's net debt to annualized EBITDA ratio improved to 3.0x, down from 3.4x at the end of 2025, demonstrating effective financial management that could enhance credit ratings and financing capabilities.
- Optimistic Outlook: Management raised the 2026 same-store NOI growth guidance to 9% to 12% and increased the NFFO per share guidance to $2.03 to $2.09, reflecting confidence in future market demand and likely attracting more investor interest.
See More
American Healthcare REIT (AHR) Q1 2026 Transcript
See More
Welltower Shares Face Downside Risk Amidst Aggressive Compensation Concerns
- Executive Compensation Controversy: Welltower's ten-year executive program may facilitate a transfer of wealth from shareholders to management, with CEO Shankh Mitra's potential award reaching approximately $2.6 billion, raising serious governance concerns that could undermine investor confidence.
- Significant Valuation Risks: Currently trading at $300 per share, Welltower's valuation is estimated to be 35%-60% higher than peer averages, indicating a potential for substantial downside, prompting investors to carefully assess their holding risks.
- Investor Migration Trend: With Welltower's asset value trading at a 144% premium compared to Ventas and American Healthcare REIT, investors switching to these alternatives could receive 50% more asset value, reflecting market dissatisfaction with aggressive executive compensation structures.
- Historical Lessons as Warnings: Alexandria Real Estate Equities' stock peaked at $224 in 2021 but plummeted 80% due to excessive management compensation and market cycle changes, serving as a cautionary tale for Welltower shareholders to remain vigilant against similar risks.
See More
